Portfolio
Courage Therapeutics
Courage Therapeutics' two drug-development programs aim to address obesity and restrictive eating disorders, such as anorexia nervosa and cachexia, by targeting neural circuits in the brain known as the central melanocortin system.(2025)
Genevi Technologies
Developing a medical device to treat stress urinary incontinence.(2025)
NanoOnco
NanoOnco is developing a bioabsorbable magnesium device designed to control cancer and cancer metastasis.(2025)
Ocutheia
Ocutheia is developing a small molecule as monotherapy for dry and wet age-related macular degeneration.(2025)
Rewind
Rewind is a proven clinical program that targets the fundamentals of metabolic disease: biology and lifestyle to fight type 2 diabetes.(2025)
ALLInBio, Inc.
Therapeutics for rheumatoid arthritis and potentially other autoimmune disorders.(2024)
Be BioInnovations
Developing and disseminating human squamous cell carcinoma cell lines.(2024)
Grasp Robotics
Artificial joints for robotic/prosthetic applications that mimic human speed and strength.(2024)
Health Technology Innovations
Managing and marketing the licensing of the worlds largest, most comprehensive and expertly curated medical synonyms list for applications across a broad set of digital health applications.(2024)
NanoVascular
Bioabsorbable magnesium alloy devices for hemodialysis vascular access, enhancing efficiency and patient outcomes with their BioFlow product.(2024)
Rua Diagnostics
Breath diagnostic for detection of ARDS, sepsis, and various cancers.(2024)